Loading clinical trials...
Loading clinical trials...
A Phase I Study of HERV-E TCR Transduced Autologous T Cells in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Conditions
Interventions
cell infusion
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
July 20, 2018
Primary Completion Date
October 31, 2023
Completion Date
March 3, 2026
Last Updated
December 3, 2024
NCT00033137
NCT07117227
NCT05969496
NCT07123090
NCT00026884
NCT07485114
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions